{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:23:23Z","timestamp":1760865803237,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1124\/dmd.113.051862","type":"journal-article","created":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T05:17:03Z","timestamp":1369372623000},"page":"1529-1537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4"],"prefix":"10.1016","volume":"41","author":[{"given":"Hyo-Ji","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Sook","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung-Ah","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kye Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Jae","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Lyul","family":"Ghim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ryul","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Gook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.051862_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bioorg.2008.02.004","article-title":"Enzyme-assisted synthesis and structure characterization of glucuronic acid conjugates of losartan, candesartan, and zolarsartan","volume":"36","author":"Alonen","year":"2008","journal-title":"Bioorg Chem"},{"key":"10.1124\/dmd.113.051862_bib2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0076-6879(05)00007-8","article-title":"Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases","volume":"400","author":"Court","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1124\/dmd.113.051862_bib3","first-page":"1747","article-title":"Therapeutic effects of sarpogrelate hydrochloride (MCI-9042) on chronic arterial occlusive disease: a double-blind comparison with ticlopidine hydrochloride","volume":"7","author":"Furukawa","year":"1991","journal-title":"Jpn J Clin Pharmacol Ther"},{"key":"10.1124\/dmd.113.051862_bib4","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bcp.2007.01.030","article-title":"Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7","volume":"73","author":"Gaganis","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.051862_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0090-9556(25)07355-6","article-title":"Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein","volume":"24","author":"Green","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051862_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.tpj.6500171","article-title":"Pharmacogenomics of human UDP-glucuronosyltransferase enzymes","volume":"3","author":"Guillemette","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.113.051862_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-0038-1648163","article-title":"MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist","volume":"65","author":"Hara","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1124\/dmd.113.051862_bib8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/00498254.2011.563327","article-title":"N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases","volume":"41","author":"Kaivosaari","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.051862_bib9","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.bcp.2004.02.014","article-title":"Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4","volume":"67","author":"Kaku","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.113.051862_bib10","first-page":"353","article-title":"Study of the metabolic fate of (\u00b1)-2-(dimethyl-amino)-1-[[o-(m-methoxyphenethyl)-phenoxy]methyl]ethyl hydrogen succinate hydrochloride (MCI-9042). (I). Metabolism of MCI-9042 in rats, dogs, monkeys and human","volume":"6","author":"Kamatsu","year":"1992","journal-title":"Yakubutsu Dotai"},{"key":"10.1124\/dmd.113.051862_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/1389200003339171","article-title":"UDP-glucuronosyltransferases","volume":"1","author":"King","year":"2000","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.113.051862_bib12","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00004714-200110000-00008","article-title":"Drug glucuronidation in clinical psychopharmacology","volume":"21","author":"Liston","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1124\/dmd.113.051862_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/03602530903210716","article-title":"The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential","volume":"42","author":"Miners","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.113.051862_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1538-7836.2005.01702.x","article-title":"Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery","volume":"4","author":"Nishihira","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1124\/dmd.113.051862_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2009.12.005","article-title":"Enzyme-assisted synthesis and structural characterization of pure benzodiazepine glucuronide epimers","volume":"39","author":"Pallmann","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.113.051862_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0024-3205(03)00227-3","article-title":"Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling","volume":"73","author":"Rashid","year":"2003","journal-title":"Life Sci"},{"key":"10.1124\/dmd.113.051862_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1124\/jpet.110.167916","article-title":"In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans","volume":"334","author":"Raungrut","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.051862_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1527-3466.2004.tb00130.x","article-title":"Therapeutic potentials of sarpogrelate in cardiovascular disease","volume":"22","author":"Saini","year":"2004","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1124\/dmd.113.051862_bib19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1248\/yakushi1947.119.11_850","volume":"119","author":"Shimizu","year":"1999","journal-title":"Yakugaku Zasshi"},{"key":"10.1124\/dmd.113.051862_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","article-title":"Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6","volume":"27","author":"Shin","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051862_bib21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/STROKEAHA.107.505131","article-title":"Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial","volume":"39","author":"Shinohara","year":"2008","journal-title":"Stroke"},{"key":"10.1124\/dmd.113.051862_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/00498250110069690","article-title":"Evaluation of the marmoset as a model species for drug glucuronidation","volume":"31","author":"Soars","year":"2001","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.113.051862_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1527-3466.1997.tb00326.x","article-title":"MCI-9042, the new selective antagonist of serotonergic (5-HT2A) receptors","volume":"15","author":"Takada","year":"1997","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1124\/dmd.113.051862_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human udp-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051862_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.2006.02588.x","article-title":"Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation","volume":"61","author":"Uchaipichat","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.113.051862_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/dmd.107.017962","article-title":"Characterization of 1\u2032-hydroxymidazolam glucuronidation in human liver microsomes","volume":"36","author":"Zhu","year":"2008","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.051862","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:10:29Z","timestamp":1739905829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624097848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0090955624097848"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.051862","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.051862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}